Back to Results
First PageMeta Content
Clinical trial / Ipsen / Biomarker / TroVax / Oncolytics Biotech / Medicine / Health / Prostate cancer


Active Biotech and Ipsen announce completion of recruitment of tasquinimod clinical phase III study in prostate cancer
Add to Reading List

Document Date: 2012-12-09 11:48:23


Open Document

File Size: 71,60 KB

Share Result on Facebook
UPDATE